ÂÜÀòÂÒÂ×

Professor Ulven has >12 years of experience with medicinal chemistry and management of drug discovery projects, including projects aimed at GPR40 and other free fatty acid receptors since 2006. Before joining SDU in 2005, he was senior scientist and project leader at 7TM Pharma A/S, a biotech company focusing on discovery of therapeutics for metabolic diseases. Professor Ulven has been leading an independent research group at SDU since 2005 and has >85 publications (h-index 28, >1900 citations) and 20 patents and patent applications.